Halozyme Therapeutics : HALO

All Halozyme Therapeutics Articles

52 Articles

Lee Jackson | Dec 24, 2014 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Monsanto, Virgin America and More

Wednesday's top analyst upgrades, downgrades and initiations from top research calls from around Wall Street include Monsanto and Virgin America.

Jon C. Ogg | Jul 17, 2014 at 3:06 PM EDT

4 Key Positive Biotech Stock Catalysts Coming Very Soon

ThinkstockInvestors and speculators often flock to the world biotech for emerging drugs of the future. It is no secret at…

Jon C. Ogg | Jul 12, 2014 at 9:21 AM EDT

12 Analyst Stocks to Buy Under $10 With Massive Upside Potential

Stocks are looking for their footing after having hit new all-time highs in the prior week. Volatility has returned, but…

Jon C. Ogg | Jun 14, 2014 at 11:10 AM EDT

Twelve Analyst Stocks Trading Under $10 With Huge Implied Upside

ThinkstockStocks have pulled back from their all-time highs after escalation of civil war in Iraq, but Friday managed to close…

Jon C. Ogg | Jun 12, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple,…

Jon C. Ogg | Jun 5, 2014 at 11:15 AM EDT

Halozyme Gets New Hope for Shareholders, and for Pancreatic Cancer Patients

Halozyme Therapeutics saw its stock surge on Thursday on news reports that the FDA has removed its clinical hold on…

Jon C. Ogg | Apr 15, 2014 at 8:25 AM EDT

Top Analyst Upgrades and Downgrades: Citigroup, Equinix, IBM, Visa, Yahoo, Walmart and More

These are the top analyst upgrades, downgrades and initiations from Wall Street on Tuesday, April 15, 2014. They include Citigroup,…

Jon C. Ogg | Apr 4, 2014 at 8:30 AM EDT

Pancreatic Cancer Trial Enrollment Halt Damages Halozyme

Halozyme Therapeutics shares are getting pounded on Friday on news of a temporary halt of its Phase II trial enrollment…

Jon C. Ogg | Jan 27, 2014 at 8:50 AM EST

Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside

Once again, the analysts at Piper Jaffray are conducting extensive management meetings with the companies they cover. Here are the…

Jon C. Ogg | May 15, 2013 at 8:40 AM EDT

Top Analyst Upgrades and Stocks to Buy: Ciena, Gap, Halcon and More

Investors and traders are always on the lookout for fresh research ideas that will lead to higher income or more…

Jon C. Ogg | Mar 28, 2013 at 8:50 AM EDT

Top Biotech-Pharma Stock Ideas With Continued Big Upside (OREX, HALO, BAX, BMRN)

ThinkstockMuch of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best…

Paul Ausick | Mar 25, 2013 at 4:25 PM EDT

Market Close: Big Winners & Losers for March 25, 2013 (STXS, NVGN, LEDS, HZNP, BVX, IDIX, TOPS, SINO, PGTI, HALO)

thinkstockHere are today’s five biggest gaining stocks at closing: Stereotaxis Inc. (NASDAQ: STXS) is up 30.2% at $2.33. Novogen Ltd.…

Paul Ausick | Mar 22, 2013 at 4:26 PM EDT

Market Close: Big Winners & Losers for March 22, 2013 (TOPS, HALO, ANAC, MRIN, SINO, AMBO, GALT, TIBX, DGICB, HSOL)

thinkstockHere are today’s five biggest gaining stocks at closing: Top Ships Inc. (NASDAQ: TOPS) is up 39% at $1.39. Halozyme…

Paul Ausick | Dec 21, 2012 at 4:05 PM EST

24/7 Wall St. Closing Bell — December 21, 2012: Markets Gloomy All Day (MDRX, GG, NKE, EAT, DFS, RHT, WAG, SMRT, RIMM, ASCA, PNK, DQ, HLF, HALO, PFE)

U.S. equity markets opened lower this morning following last night’s failure by the U.S. House of Representatives to hold a…

247sam | Sep 21, 2012 at 10:46 AM EDT

Today’s Market Winners and Losers

Photo by Spencer Platt/Getty ImagesThe stock market is up Friday, with the Dow Jones Industrial Average up 0.33%, the Nasdaq…

1 2 3 4

Halozyme Therapeutics : HALO

All Halozyme Therapeutics Articles

Top Analyst Upgrades and Downgrades: Monsanto, Virgin America and More

4 Key Positive Biotech Stock Catalysts Coming Very Soon

12 Analyst Stocks to Buy Under $10 With Massive Upside Potential

Twelve Analyst Stocks Trading Under $10 With Huge Implied Upside

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

Halozyme Gets New Hope for Shareholders, and for Pancreatic Cancer Patients

Top Analyst Upgrades and Downgrades: Citigroup, Equinix, IBM, Visa, Yahoo, Walmart and More

Pancreatic Cancer Trial Enrollment Halt Damages Halozyme

Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside

Top Analyst Upgrades and Stocks to Buy: Ciena, Gap, Halcon and More

Top Biotech-Pharma Stock Ideas With Continued Big Upside (OREX, HALO, BAX, BMRN)

Market Close: Big Winners & Losers for March 25, 2013 (STXS, NVGN, LEDS, HZNP, BVX, IDIX, TOPS, SINO, PGTI, HALO)

Market Close: Big Winners & Losers for March 22, 2013 (TOPS, HALO, ANAC, MRIN, SINO, AMBO, GALT, TIBX, DGICB, HSOL)

24/7 Wall St. Closing Bell — December 21, 2012: Markets Gloomy All Day (MDRX, GG, NKE, EAT, DFS, RHT, WAG, SMRT, RIMM, ASCA, PNK, DQ, HLF, HALO, PFE)

Today’s Market Winners and Losers

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Halozyme Therapeutics : HALO

All Halozyme Therapeutics Articles

Top Analyst Upgrades and Downgrades: Monsanto, Virgin America and More

4 Key Positive Biotech Stock Catalysts Coming Very Soon

12 Analyst Stocks to Buy Under $10 With Massive Upside Potential

Twelve Analyst Stocks Trading Under $10 With Huge Implied Upside

Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More

Halozyme Gets New Hope for Shareholders, and for Pancreatic Cancer Patients

Top Analyst Upgrades and Downgrades: Citigroup, Equinix, IBM, Visa, Yahoo, Walmart and More

Pancreatic Cancer Trial Enrollment Halt Damages Halozyme

Piper Jaffray’s Seven Biotech Stocks to Buy With Huge Potential Upside

Top Analyst Upgrades and Stocks to Buy: Ciena, Gap, Halcon and More

Top Biotech-Pharma Stock Ideas With Continued Big Upside (OREX, HALO, BAX, BMRN)

Market Close: Big Winners & Losers for March 25, 2013 (STXS, NVGN, LEDS, HZNP, BVX, IDIX, TOPS, SINO, PGTI, HALO)

Market Close: Big Winners & Losers for March 22, 2013 (TOPS, HALO, ANAC, MRIN, SINO, AMBO, GALT, TIBX, DGICB, HSOL)

24/7 Wall St. Closing Bell — December 21, 2012: Markets Gloomy All Day (MDRX, GG, NKE, EAT, DFS, RHT, WAG, SMRT, RIMM, ASCA, PNK, DQ, HLF, HALO, PFE)

Today’s Market Winners and Losers

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened